Publication | Closed Access
712P CAPT: A multicenter randomized controlled trial of perioperative versus postoperative camrelizumab plus apatinib for resectable hepatocellular carcinoma
11
Citations
0
References
2022
Year
No additional data available for this publication yet. Check back later!